These results provide new evidence of the relationship between disease stage and PD-L1 expression in CLL, and suggest that p66Shc deficiency in CLL cells from patients with aggressive disease impinges in T cell suppression by enhancing PD-L1 expression. This evidence concerns the gene CD274 and B-cell chronic lymphocytic leukemia.